🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 30,787 shares of common stock, valued at approximately $2,340,024.43, on 09/21/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 30,787 shares of common stock, valued at approximately $2,340,024.43, on 09/21/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
September 21, 2026 at 8:05 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 30,787 shares of common stock, valued at approximately $2,340,024.43, on 09/21/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 30,787 shares of common stock, valued at approximately $2,340,024.43, on 09/21/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,789 shares of common stock, valued at approximately $459,560.92, on 08/27/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,789 shares of common stock, valued at approximately $459,560.92, on 08/27/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 27, 2026 at 9:08 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,789 shares of common stock, valued at approximately $459,560.92, on 08/27/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,789 shares of common stock, valued at approximately $459,560.92, on 08/27/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 10,551 shares of common stock, valued at approximately $839,338.38, on 08/25/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 10,551 shares of common stock, valued at approximately $839,338.38, on 08/25/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 25, 2026 at 8:57 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 10,551 shares of common stock, valued at approximately $839,338.38, on 08/25/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 10,551 shares of common stock, valued at approximately $839,338.38, on 08/25/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,762 shares of common stock, valued at approximately $458,185.02, on 08/24/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,762 shares of common stock, valued at approximately $458,185.02, on 08/24/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 24, 2026 at 9:24 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,762 shares of common stock, valued at approximately $458,185.02, on 08/24/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 5,762 shares of common stock, valued at approximately $458,185.02, on 08/24/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 100,000 shares of common stock, valued at approximately $7,954,105.00, on 08/19/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 100,000 shares of common stock, valued at approximately $7,954,105.00, on 08/19/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 19, 2026 at 8:11 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 100,000 shares of common stock, valued at approximately $7,954,105.00, on 08/19/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 100,000 shares of common stock, valued at approximately $7,954,105.00, on 08/19/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 52,438 shares of common stock, valued at approximately $4,034,894.35, on 08/17/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 52,438 shares of common stock, valued at approximately $4,034,894.35, on 08/17/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 8:21 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 52,438 shares of common stock, valued at approximately $4,034,894.35, on 08/17/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 52,438 shares of common stock, valued at approximately $4,034,894.35, on 08/17/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 19,364 shares of common stock, valued at approximately $1,452,635.00, on 08/14/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 19,364 shares of common stock, valued at approximately $1,452,635.00, on 08/14/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 11:01 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 19,364 shares of common stock, valued at approximately $1,452,635.00, on 08/14/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 19,364 shares of common stock, valued at approximately $1,452,635.00, on 08/14/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 25,989 shares of common stock, valued at approximately $1,973,970.86, on 08/13/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 25,989 shares of common stock, valued at approximately $1,973,970.86, on 08/13/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 13, 2026 at 9:20 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 25,989 shares of common stock, valued at approximately $1,973,970.86, on 08/13/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 25,989 shares of common stock, valued at approximately $1,973,970.86, on 08/13/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 32,137 shares of common stock, valued at approximately $2,526,514.53, on 08/12/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 32,137 shares of common stock, valued at approximately $2,526,514.53, on 08/12/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 12, 2026 at 9:58 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 32,137 shares of common stock, valued at approximately $2,526,514.53, on 08/12/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 32,137 shares of common stock, valued at approximately $2,526,514.53, on 08/12/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,810,255.00, on 08/11/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,810,255.00, on 08/11/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 11, 2026 at 10:20 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,810,255.00, on 08/11/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,810,255.00, on 08/11/2026.
🚨 $CGON
144 Analysis Error: HTTPSConnectionPool(host='www.sec.gov', port=443): Read timed out. (read timeout=10)
144 Analysis Error: HTTPSConnectionPool(host='www.sec.gov', port=443): Read timed out. (read timeout=10)
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 7, 2026 at 9:19 PM
🚨 $CGON
144 Analysis Error: HTTPSConnectionPool(host='www.sec.gov', port=443): Read timed out. (read timeout=10)
144 Analysis Error: HTTPSConnectionPool(host='www.sec.gov', port=443): Read timed out. (read timeout=10)
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 75,000 shares of common stock, valued at approximately $5,672,212.50, on 08/06/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 75,000 shares of common stock, valued at approximately $5,672,212.50, on 08/06/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 6, 2026 at 8:37 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 75,000 shares of common stock, valued at approximately $5,672,212.50, on 08/06/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 75,000 shares of common stock, valued at approximately $5,672,212.50, on 08/06/2026.
CG Oncology (CGON) Projected to Announce Earnings on Friday
CG Oncology (NASDAQ:CGON – Get Free Report) is expected to release its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.6642) per share and revenue of $0.3610 million for…
CG Oncology (NASDAQ:CGON – Get Free Report) is expected to release its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.6642) per share and revenue of $0.3610 million for…
CG Oncology (CGON) Projected to Announce Earnings on Friday
CG Oncology (NASDAQ:CGON – Get Free Report) is expected to release its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.6642) per share and revenue of $0.3610 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning [...]
news-area.com
August 6, 2026 at 5:59 PM
CG Oncology (CGON) Projected to Announce Earnings on Friday
CG Oncology (NASDAQ:CGON – Get Free Report) is expected to release its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.6642) per share and revenue of $0.3610 million for…
CG Oncology (NASDAQ:CGON – Get Free Report) is expected to release its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.6642) per share and revenue of $0.3610 million for…
CG Oncology ($CGON) reported EPS of -0.9 missing estimate of -0.65 for Q2 2026. Revenue 1.157 Million Vs 831792.0 expected.
https://fundspec.ai
Don't just watch CGON move, predict it! Build your own custom AI trading models for CGON today by downloading the FundSpec App on the AppStore or PlayStore!
https://fundspec.ai
Don't just watch CGON move, predict it! Build your own custom AI trading models for CGON today by downloading the FundSpec App on the AppStore or PlayStore!
August 6, 2026 at 12:55 PM
CG Oncology ($CGON) reported EPS of -0.9 missing estimate of -0.65 for Q2 2026. Revenue 1.157 Million Vs 831792.0 expected.
https://fundspec.ai
Don't just watch CGON move, predict it! Build your own custom AI trading models for CGON today by downloading the FundSpec App on the AppStore or PlayStore!
https://fundspec.ai
Don't just watch CGON move, predict it! Build your own custom AI trading models for CGON today by downloading the FundSpec App on the AppStore or PlayStore!
CG Oncology's Q2 Loss Widens 91% on Soaring Pre-Commercial Costs, Overshadowing Revenue Beat https://signalbloom.ai/news/CGON/cg-oncologys-q2-loss-widens-91-on-soaring-pre-commercial-costs-overshadowing-revenue-beat $CGON #Earnings via @signalbloom.ai
August 6, 2026 at 12:33 PM
CG Oncology's Q2 Loss Widens 91% on Soaring Pre-Commercial Costs, Overshadowing Revenue Beat https://signalbloom.ai/news/CGON/cg-oncologys-q2-loss-widens-91-on-soaring-pre-commercial-costs-overshadowing-revenue-beat $CGON #Earnings via @signalbloom.ai
🚨 $CGON
On August 6, 2026, CG Oncology, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
On August 6, 2026, CG Oncology, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
August 6, 2026 at 12:31 PM
🚨 $CGON
On August 6, 2026, CG Oncology, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
On August 6, 2026, CG Oncology, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
#CGON CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
https://www.stocktitan.net/news/CGON/cg-oncology-reports-second-quarter-2026-financial-results-and-90u5yprbfrk7.html
https://www.stocktitan.net/news/CGON/cg-oncology-reports-second-quarter-2026-financial-results-and-90u5yprbfrk7.html
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk NMIBC anticipated in the near-term BLA completion for HR BCG-unresponsive NMIBC expected fourth quarter 2026 Phase 3 BOND-003 Cohort C Study Results published in The Lancet Oncology,
www.stocktitan.net
August 6, 2026 at 12:15 PM
#CGON CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
https://www.stocktitan.net/news/CGON/cg-oncology-reports-second-quarter-2026-financial-results-and-90u5yprbfrk7.html
https://www.stocktitan.net/news/CGON/cg-oncology-reports-second-quarter-2026-financial-results-and-90u5yprbfrk7.html
SELL $CGON (CGON.O) [StockDilution] @ 12:02:58Z
August 6, 2026 at 12:02 PM
SELL $CGON (CGON.O) [StockDilution] @ 12:02:58Z
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
July 28, 2026 at 9:30 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
July 28, 2026 at 9:29 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,625,195.00, on 07/28/2026.
#CGON CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
https://www.stocktitan.net/news/CGON/cg-oncology-announces-publication-of-pivotal-phase-3-bond-003-cohort-9nttyh7hxagd.html
https://www.stocktitan.net/news/CGON/cg-oncology-announces-publication-of-pivotal-phase-3-bond-003-cohort-9nttyh7hxagd.html
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
CG Oncology (NASDAQ: CGON) reported that pivotal Phase 3 BOND-003 Cohort C results for intravesical cretostimogene grenadenorepvec monotherapy in high-risk, BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ were published in The Lancet Oncology. The single-arm trial met its primary endpoint with statistical significance, with 75.5% of patients achieving a complete response at any time.According to CG Oncology, 12- and 24-month duration of response rates were 64.2% and 60.1%, with median duration of response at least 27.9 months and ongoing, and one patient disease-free beyond 51 months. Approximately 89% of patients maintained their bladders at 12 months and 81% at 24 months, while 96.6% remained free from progression to muscle-invasive disease at 48 and 96 weeks. No Grade 3 or higher treatment-related adverse events, discontinuations, or deaths were reported, and administration is office-based without need for prophylactic medication, operating room time, or anesthesia.
www.stocktitan.net
July 27, 2026 at 10:46 PM
#CGON CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
https://www.stocktitan.net/news/CGON/cg-oncology-announces-publication-of-pivotal-phase-3-bond-003-cohort-9nttyh7hxagd.html
https://www.stocktitan.net/news/CGON/cg-oncology-announces-publication-of-pivotal-phase-3-bond-003-cohort-9nttyh7hxagd.html
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,627,995.00, on 07/27/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,627,995.00, on 07/27/2026.
SEC Filing: CGON
Click to view the official SEC document.
www.sec.gov
July 27, 2026 at 8:02 PM
🚨 $CGON
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,627,995.00, on 07/27/2026.
AMBAW BELLETE, a Officer, filed a notice of intent to sell 50,000 shares of common stock, valued at approximately $3,627,995.00, on 07/27/2026.
